Stoke Therapeutics, Inc. (STOK) Tops Q1 Earnings and Revenue Estimates

Stoke Therapeutics, Inc. (STOK) came out with quarterly earnings of $1.90 per share, beating the Zacks Consensus Estimate of a loss of$ 0.37 per share. This compares to loss of $0.57 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 613.51%. A quarter ago, it was expected that this company would post a loss of$ 0.51 per share when it actually produced a loss of $0.18, delivering a surprise of 64.71%.Over the last four quarters, ...